Suspected Cerebral Hyperperfusion Syndrome after Stenting for Intracranial Vertebral Artery Stenosis Associated with Reduced Cerebral Blood Flow to the Posterior Cerebral Artery Territory.
cerebral hyperperfusion syndrome
posterior circulation
single photon emission computed tomography
stenting
Journal
Journal of neuroendovascular therapy
ISSN: 2186-2494
Titre abrégé: J Neuroendovasc Ther
Pays: Japan
ID NLM: 101488164
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
08
2020
accepted:
22
10
2020
medline:
1
1
2021
pubmed:
1
1
2021
entrez:
28
7
2023
Statut:
ppublish
Résumé
Although several studies have reported on cerebral hyperperfusion syndrome (CHS)/hyperperfusion phenomenon (HPP) involving the anterior circulation after carotid artery stenting (CAS), little is known about CHS/HPP involving the posterior circulation after percutaneous transluminal angioplasty (PTA) and stenting of the vertebral artery (VA). A 79-year-old man with known chronic occlusion of the left VA (V4 segment) was admitted to another hospital with right-sided hemiplegia, mild disturbance of consciousness, and dysphagia. A head MRI revealed multiple infarcts in posterior circulation areas, and severe stenosis of the right VA (V4 segment). Single photon emission computed tomography (SPECT) indicated reduced cerebral blood flow (CBF) in the posterior circulation, and DSA revealed 76% stenosis of the right V4 segment. On day 18, PTA/stenting was performed under general anesthesia for the severe stenosis of the right VA. However, head MRI and CT on postoperative day (POD)1 showed intracranial hemorrhage (ICH) occupying an area measuring 2 cm in diameter in the left posterior lobe and a small subdural hematoma (SDH). SPECT on POD1 indicated increased CBF in the posterior lobe, and we diagnosed CHS might have caused ICH. Although SPECT on POD4 showed residual hyperperfusion, SPECT on POD11 revealed reduced CBF in the posterior circulation area. Our patient developed ICH after undergoing PTA/stenting for known severe symptomatic stenosis of the right VA. CHS/HPP in the posterior cerebral artery territory might be one of the etiologies, and reduced CBF prior to the procedure could be a risk factor for CHS/HPP developing after PTA/stenting.
Identifiants
pubmed: 37502784
doi: 10.5797/jnet.cr.2020-0159
pii: jnet.cr.2020-0159
pmc: PMC10370887
doi:
Types de publication
Case Reports
Langues
eng
Pagination
460-466Informations de copyright
©2021 The Japanese Society for Neuroendovascular Therapy.
Déclaration de conflit d'intérêts
The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.
Références
Neurosurgery. 2017 Sep 1;81(3):512-519
pubmed: 28368507
J Neurosurg. 2007 Dec;107(6):1130-6
pubmed: 18077950
Neurol Med Chir (Tokyo). 2015;55(2):141-8
pubmed: 25746308
J Neurosurg. 2001 May;94(5):826-30
pubmed: 11354418
Lancet Neurol. 2015 Jun;14(6):606-14
pubmed: 25908089
J Vasc Surg. 2009 Apr;49(4):1060-8
pubmed: 19249185
Exp Transl Stroke Med. 2016 Sep 06;8(1):7
pubmed: 27602202
Lancet Neurol. 2005 Dec;4(12):877-88
pubmed: 16297845
Stroke. 2005 Jan;36(1):21-6
pubmed: 15576656
Cerebrovasc Dis. 2013;35(6):531-7
pubmed: 23817298
Neurology. 2017 Sep 19;89(12):1229-1236
pubmed: 28835400
Ann Vasc Surg. 2009 Sep-Oct;23(5):686.e1-5
pubmed: 18973983
Neurosurgery. 2009 Mar;64(3 Suppl):ons122-8; discussion ons128-9
pubmed: 19240561
Neurosurgery. 2000 Aug;47(2):335-43; discussion 343-5
pubmed: 10942006
Stroke. 2006 Jan;37(1):e12-4
pubmed: 16339466
World Neurosurg. 2020 Aug;140:101-106
pubmed: 32428717
J Neurol. 1997 Feb;244(2):101-4
pubmed: 9120491
J Stroke Cerebrovasc Dis. 2014 Mar;23(3):583-6
pubmed: 23721618